| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.25B | 83.67B | 86.38B | 97.06B | 96.25B | 89.60B |
| Gross Profit | 26.48B | 26.15B | 27.13B | 30.49B | 30.39B | 28.17B |
| EBITDA | 12.48B | 12.59B | 13.57B | 12.69B | 14.47B | 10.68B |
| Net Income | 6.78B | 6.96B | 7.73B | 6.44B | 8.44B | 5.83B |
Balance Sheet | ||||||
| Total Assets | 53.45B | 44.57B | 43.36B | 45.27B | 46.33B | 48.29B |
| Cash, Cash Equivalents and Short-Term Investments | 1.03B | 2.13B | 1.23B | 1.73B | 1.40B | 5.20B |
| Total Debt | 44.70B | 39.68B | 40.15B | 37.99B | 29.38B | 26.21B |
| Total Liabilities | 63.84B | 58.80B | 58.41B | 59.53B | 51.15B | 46.85B |
| Stockholders Equity | -10.38B | -14.23B | -15.05B | -14.25B | -4.82B | 1.44B |
Cash Flow | ||||||
| Free Cash Flow | 7.05B | 7.70B | 6.18B | 6.76B | 8.26B | 9.26B |
| Operating Cash Flow | 9.21B | 9.63B | 8.14B | 8.59B | 10.11B | 11.05B |
| Investing Cash Flow | -12.11B | -1.74B | -1.90B | -1.31B | -1.65B | -1.89B |
| Financing Cash Flow | 247.00M | -7.05B | -6.67B | -7.05B | -12.02B | -5.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $25.54B | 23.52 | 56.92% | 1.37% | 5.10% | 7.59% | |
69 Neutral | $158.26B | 23.39 | ― | 1.94% | 0.64% | 0.58% | |
67 Neutral | $27.76B | 25.50 | 45.18% | 1.80% | 4.26% | 0.73% | |
66 Neutral | $381.80B | 26.15 | 162.91% | 2.67% | 7.50% | -0.38% | |
62 Neutral | $14.02B | 22.09 | 22.49% | 5.46% | -0.95% | -48.28% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | $7.54B | 33.06 | 9.11% | ― | 6.04% | 10.26% |